Altos Labs
About Altos Labs
Altos Labs is a biotechnology company focused on restoring cell health and resilience through cell rejuvenation programming to reverse disease, injury, and disabilities that can occur throughout life. The organization emphasizes understanding deep biology of cell rejuvenation and translating that science into breakthrough medicine. It operates as a life sciences research entity with initiatives such as the Institute of Computation and collaborative efforts across disciplines to advance regenerative medicine. Based on public statements and press coverage, Altos Labs positions itself as a leader in cellular rejuvenation to transform medicine.
Recent News
Life Bio’s Trial: Is the FDA Warming to Rejuvenation?
The Fifteen-Year-Old Who Just Earned a PhD and Is Specialising in Immortality
Wealth Is Health, Insider Betting & Trump Will See Himself in Court
Just ‘Stay Alive for the Next 10 Years’ – Anti-Ageing Drugs Are Coming, Says Billionaire Investor
A Better Algorithm for Predicting How Cells Behave
A Great Deal More Funding for the Development of Partial Reprogramming Therapies
Electromagnetic Field Activation of Gene Therapy as an Approach to Reprogramming
Harvard Publishes a Longevity Report for the General Public
Free Radicals Podcast (Longevity / Biotech Oriented)
Life Biosciences Prepares First Human Trial of Partial Cellular Reprogramming for Glaucoma
Remaining Challenges in the Development of Partial Reprogramming Therapies
Longevity Science Picks up Steam in Pharma
The Tech Billionaires Behind the Immortality Movement
This Method to Reverse Cellular Aging Is About to Be Tested in Humans
Partial Reprogramming Concern Altos Labs Is Becoming Less Stealthy
Altos Labs' Izpisua Says Aging Is Cellular Identity Loss, Unveils New Data in Madrid
Why “Reprogramming” Is the Buzziest Approach to Reversing Aging Right Now
Recent Deals
No recent deals for this company.